Advanced search
Publication Cover
Current Medical Research and Opinion Volume 32, 2016 - Issue 9
Submit an article Journal homepage
108
Views
13
CrossRef citations to date
0
Altmetric
Diabetes

Cardiovascular effects of sodium–glucose cotransporter 2 inhibitors: multiple actions

Niki Katsiki 12 Dionyssiou St, Thessaloniki, 546 34, Greece; Correspondence[email protected]
,
Vasilios G. AthyrosSecond Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece;
&
Dimitri P. MikhailidisDepartment of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London (UCL), Pond Street, LondonNW3 2QG, UK
Pages 1513-1514 | Received 31 May 2016, Accepted 31 May 2016, Published online: 14 Jul 2016

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Niki Katsiki, Kalliopi Kotsa & Vasilios Kotsis. (2020) Empagliflozin effects on cardiac remodeling: re-shaping the future of heart failure prevention. Expert Review of Cardiovascular Therapy 18:11, pages 841-842.
Read now
Niki Katsiki, Francesco Purrello, Costas Tsioufis & Dimitri P. Mikhailidis. (2017) Cardiovascular disease prevention strategies for type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 18:12, pages 1243-1260.
Read now

Articles from other publishers (11)

Niki Katsiki, Paschalis Steiropoulos, Nikolaos Papanas & Dimitri P. Mikhailidis. (2019) Diabetes Mellitus and Chronic Obstructive Pulmonary Disease: An Overview. Experimental and Clinical Endocrinology & Diabetes 129:10, pages 699-704.
Crossref
Niki Katsiki, Kalliopi Kotsa, Anca P. Stoian & Dimitri P. Mikhailidis. (2020) Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes. Current Pharmaceutical Design 26:43, pages 5637-5649.
Crossref
Golnaz Ranjbar, Dimitri P. Mikhailidis & Amirhossein Sahebkar. (2019) Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!. Metabolism 101, pages 154001.
Crossref
Genovefa D. Kolovou, Gerald F. Watts, Dimitri P. Mikhailidis, Pablo Pérez-Martínez, Samia Mora, Helen Bilianou, George Panotopoulos, Niki Katsiki, Teik C. Ooi, José Lopez-Miranda, Anne Tybjærg-Hansen, Nicholas Tentolouris & Børge G. Nordestgaard. (2019) Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review. Current Vascular Pharmacology 17:5, pages 515-537.
Crossref
Niki Katsiki, George Dimitriadis, George Hahalis, Nikolaos Papanas, Nikolaos Tentolouris, Filippos Triposkiadis, Vasilios Tsimihodimos, Costas Tsioufis, Dimitri P. Mikhailidis & Christos Mantzoros. (2019) Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence. Metabolism 96, pages 92-100.
Crossref
Niki Katsiki & Filippos Triposkiadis. (2019) Resistance to Diuretics in Heart Failure: Any Role for Empagliflozin?. Current Vascular Pharmacology 17:4, pages 421-424.
Crossref
Munehisa Bekki, Nobuhiro Tahara, Atsuko Tahara, Sachiyo Igata, Akihiro Honda, Yoichi Sugiyama, Tomohisa Nakamura, Jiahui Sun, Yuki Kumashiro, Takanori Matsui, Yoshihiro Fukumoto & Sho-ichi Yamagishi. (2019) Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study. Current Vascular Pharmacology 17:4, pages 411-420.
Crossref
Habib Yaribeygi, Stephen L. Atkin, Niki Katsiki & Amirhossein Sahebkar. (2018) Narrative review of the effects of antidiabetic drugs on albuminuria. Journal of Cellular Physiology 234:5, pages 5786-5797.
Crossref
Habib Yaribeygi, Stephen L. Atkin & Amirhossein Sahebkar. (2019) Mechanistic effects of SGLT2 inhibition on blood pressure in diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:2, pages 1679-1683.
Crossref
Habib Yaribeygi, Niki Katsiki, Behzad Behnam, Helia Iranpanah & Amirhossein Sahebkar. (2018) MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment. Metabolism 87, pages 48-55.
Crossref
Niki Katsiki, Dimitri P Mikhailidis & Maciej Banach. (2018) Leptin, cardiovascular diseases and type 2 diabetes mellitus. Acta Pharmacologica Sinica 39:7, pages 1176-1188.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.